Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00084656
Status:
COMPLETED
Last Update Posted:
2022-04-14
First Post:
2004-06-10
Brief Title:
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
Sponsor:
Organization:
Bristol-Myers Squibb